Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.

Diagnostics (Basel) · 2022 · PMC9320760 · PMID 35885666

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

ate measurements using gamma probes positioned in the ceiling: patients with absorbed dose to blood exceeding 0.35 Gy (144 patients) had a significantly higher probability of successful ablation (63.9% ) than the other 305 patients (ablation rate 53.1%, p = 0.03), with a dose–response curve showing an increasing trend with the increase of the absorbed dose to blood.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.